The prevalence of osteoarthritis (OA) in dogs is nearly 40%, and radiographic evidence of the condition is found in 90% of cats aged 12 or older.1-3 In Zoetis Petcare Proceedings on the Experience of Chronic Pain Ross Palmer, DVM, MS, DACVCP, referred to OA as a “silent killer” that greatly affects patients’ quality of life and overall well-being.4
Basepaws is a Zoetis company that conducts clinical research using host genetics and the state of the oral microbiome to better understand osteoarthritis and other common diseases in dogs and cats.5 Their multi-pronged approach investigates how genes contribute to the potential for disease development, as well as how the composition of the oral microbiome at any given time serves as a powerful indicator of an active, developing disease state.6 The main goal of this research is to detect diseases earlier, even before clinical signs may appear, so that patients can benefit from individualized treatment plans sooner.
Join Basepaws’ New Osteoarthritis Clinical Program
Basepaws seeks veterinary partners to help recruit DNA samples for its brand new feline and canine osteoarthritis clinical program. They provide partners with all oral swab kits and compensate for every sample that matches program criteria. Basepaws manages all aspects of the program to keep participation straightforward and easy for veterinary partners, who simply perform a quick and painless swab of a patient’s mouth as the first of three easy steps:
Basepaws welcomes the participation of veterinary professionals in a practice or university research setting who would like to help advance osteoarthritis research that could contribute to the development of an early detection test for OA in cats and dogs.
To get started, please take a few moments to fill out a short intake form on the Basepaws webpage for veterinarians at https://basepawsvet.com/research-register.